|
TMEM87A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.977300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.230700E-04 |
| Normal-vs-Stage2 |
2.534400E-01 |
| Normal-vs-Stage3 |
4.976800E-01 |
| Normal-vs-Stage4 |
8.484400E-02 |
| Stage1-vs-Stage2 |
3.550600E-01 |
| Stage1-vs-Stage3 |
8.678700E-03 |
| Stage1-vs-Stage4 |
5.095400E-01 |
| Stage2-vs-Stage3 |
4.846400E-01 |
| Stage2-vs-Stage4 |
8.020200E-01 |
| Stage3-vs-Stage4 |
2.325200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.403920E-02 |
| Normal-vs-AfricanAmerican |
4.914100E-02 |
| Normal-vs-Asian |
8.097900E-03 |
| Caucasian-vs-AfricanAmerican |
3.895600E-01 |
| Caucasian-vs-Asian |
2.110400E-01 |
| AfricanAmerican-vs-Asian |
9.460000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.854300E-02 |
| Normal-vs-Female |
3.236600E-03 |
| Male-vs-Female |
4.103400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.961600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.825670E-02 |
| Normal-vs-Age(61-80Yrs) |
8.338200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.938600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.253400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.161200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.288800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.638400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.646400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.024800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.68139999998396E-06 |
| Classical-VS-Follicular |
5.584000E-01 |
| Classical-VS-Other |
4.999000E-01 |
| Classical-VS-Normal |
3.791200E-04 |
| Tall-VS-Follicular |
7.716300E-03 |
| Tall-VS-Other |
1.925800E-01 |
| Tall-VS-Normal |
1.837820E-01 |
| Follicular-VS-Other |
7.671600E-01 |
| Follicular-VS-Normal |
8.524200E-02 |
| Other-VS-Normal |
5.652800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.587800E-02 |
| Normal-vs-N1 |
1.925980E-01 |
| N0-vs-N1 |
7.374400E-01 |
|
|
